Skip to search formSkip to main contentSkip to account menu

Embryopathies

Known as: Embryopathy 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Fetal Diseases

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Blockade of c-Jun N-terminal kinase activation abrogates hyperglycemia-induced yolk sac vasculopathy in vitro.
Review
2007
Review
2007
Neurological sequelae of intrauterine warfarin exposure
Review
2005
Review
2005
Venous thromboembolism and anticoagulant therapy in pregnancy.
Review
2002
Review
2002
Treatment and prophylaxis of venous thromboembolism during pregnancy.
Highly Cited
2000
Highly Cited
2000
Thalidomide inhibits angiogenesis in embryoid bodies by the generation of hydroxyl radicals.
Highly Cited
1998
Highly Cited
1998
Teratogenicity of 3-deoxyglucosone and diabetic embryopathy.
The increased rate of embryonic dysmorphogenesis in diabetic pregnancy is correlated with the severity and duration of the… 
Highly Cited
1997
Highly Cited
1997
Increased cell death in rat blastocysts exposed to maternal diabetes in utero and to high glucose or tumor necrosis factor-alpha in vitro.
The morphogenetic function of the transient phase of cell death that occurs during blastocyst maturation is not known but it is… 
1996
1996
Synchronization of the factors critical for diabetic teratogenesis: an in vitro model.
1996
1996
Glutathione status in diabetes-induced embryopathies.
The mechanism involved in diabetes-induced embryotoxicity is still unclear. Mitochondrial alterations probably produced by… 
1972
1972
Within-family standards for birth-weight.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)